Correlation Between Biofrontera Warrants and Minerva Neurosciences
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Minerva Neurosciences, you can compare the effects of market volatilities on Biofrontera Warrants and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Minerva Neurosciences.
Diversification Opportunities for Biofrontera Warrants and Minerva Neurosciences
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biofrontera and Minerva is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Minerva Neurosciences go up and down completely randomly.
Pair Corralation between Biofrontera Warrants and Minerva Neurosciences
Assuming the 90 days horizon Biofrontera Warrants is expected to generate 16.42 times more return on investment than Minerva Neurosciences. However, Biofrontera Warrants is 16.42 times more volatile than Minerva Neurosciences. It trades about 0.14 of its potential returns per unit of risk. Minerva Neurosciences is currently generating about 0.05 per unit of risk. If you would invest 19.00 in Biofrontera Warrants on August 31, 2024 and sell it today you would lose (11.11) from holding Biofrontera Warrants or give up 58.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 64.44% |
| Values | Daily Returns |
Biofrontera Warrants vs. Minerva Neurosciences
Performance |
| Timeline |
| Biofrontera Warrants |
| Minerva Neurosciences |
Biofrontera Warrants and Minerva Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biofrontera Warrants and Minerva Neurosciences
The main advantage of trading using opposite Biofrontera Warrants and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.| Biofrontera Warrants vs. Bausch Health Companies | Biofrontera Warrants vs. Haleon plc | Biofrontera Warrants vs. Intracellular Th |
| Minerva Neurosciences vs. Reviva Pharmaceuticals Holdings | Minerva Neurosciences vs. Eyenovia | Minerva Neurosciences vs. Cognition Therapeutics | Minerva Neurosciences vs. Transcode Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |